ACM
WST icon

Aster Capital Management’s West Pharmaceutical WST Stock Holding History

Aster Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-43
Closed -$9.63K – 1288
2026
Q1 		$9.63K Buy
+43
New +$10.7K ﹤0.01% 631
2025
Q4 		– Sell
-1,233
Closed -$323K – 1463
2025
Q3 		$323K Buy
1,233
+1,178
+2,142% +$286K 0.16% 175
2025
Q2 		$12K Buy
+55
New +$11.8K ﹤0.01% 767
2024
Q4 		– Sell
-84
Closed -$25.2K – 1569
2024
Q3 		$25.2K Buy
+84
New +$25.7K 0.01% 645

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Aster Capital Management's WST Position: Q2 2026 in Review

Aster Capital Management sold out of West Pharmaceutical (WST) in Q2 2026, closing a stake of 43 shares — an estimated $9.63K sold.

Aster Capital Management first reported a position in WST in Q3 2024 and held it in 4 quarters. The position peaked at $323K in Q3 2025. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Aster Capital Management reported no remaining West Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Aster Capital Management sold 43 West Pharmaceutical shares in Q2 2026, an estimated $9.63K.
  • Aster Capital Management first reported a position in West Pharmaceutical in Q3 2024 and held it in 4 quarters.
  • Aster Capital Management's West Pharmaceutical position peaked at $323K in Q3 2025.
  • 832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.